Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-17

Clinical Trial Update: A 4-week, Randomized, Rater-blinded, Parallel Study to Evaluate Quetiapine in Improving Sleep Quality of Schizophrenia [NA]

View source ↗

Summary

A 4-week randomized, rater-blinded study assessed quetiapine for improving sleep quality in individuals with schizophrenia; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quetiapine (quetiapine)

Snippet

Sponsor: Guang Dong Provincial Mental Health Institute | Conditions: Schizophrenia | NA | Status: COMPLETED | Results posted: 2014-04-17